Shares of Liberty Biopharma Inc (CVE:LTY – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares traded.
Liberty Biopharma Price Performance
The firm’s fifty day moving average price is C$2.00 and its 200 day moving average price is C$2.00. The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 8.19. The stock has a market cap of C$21.54 million and a PE ratio of -12.66.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
See Also
- Five stocks we like better than Liberty Biopharma
- How to Use Stock Screeners to Find Stocks
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- Best Aerospace Stocks Investing
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
